601607 上海医药
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资8,153,382-2.38%8,351,9109,232,6449,073,2756,651,064
投资性房地产332,4485.65%314,673246,415213,323235,288
固定资产11,810,317-2.84%12,155,05511,539,28910,484,11810,490,716
在建工程4,365,87022.31%3,569,6292,777,3632,914,1301,737,204
无形资产5,814,632-3.90%6,050,8366,244,1406,049,4315,195,254
商誉11,391,893-0.01%11,393,33211,335,92711,238,97211,342,268
其他非流动资产7,864,3612.09%7,703,2367,246,2536,967,8265,970,936
49,732,9010.39%49,538,67148,622,03146,941,07741,622,729

流动资产
货币资金36,676,14320.18%30,517,70627,401,39622,390,38622,296,233
应收账款80,947,31010.99%72,933,88166,759,85458,107,77052,745,906
存货35,255,345-3.74%36,623,39434,460,21727,104,03524,088,258
其他流动资产18,724,171-16.26%22,358,88120,891,4048,892,2418,432,530
171,602,9705.64%162,433,862149,512,871116,494,432107,562,926

流动负债
短期借款40,511,00513.92%35,560,50027,750,58922,514,57420,139,186
应付票据6,177,037-8.04%6,717,4445,961,7244,764,7484,930,726
应付帐款52,278,8619.11%47,915,01145,603,80537,230,66632,861,440
其他流动负债30,137,213-6.34%32,178,92531,374,92827,314,33530,201,637
129,104,1155.50%122,371,879110,691,04691,824,32488,132,990
流动资产净值42,498,8556.08%40,061,98338,821,82524,670,10919,429,937
资产总额减流动负债92,231,7572.94%89,600,65587,443,85571,611,18661,052,666

非流动负债
长期借款6,599,38114.05%5,786,1556,259,7997,157,7521,184,078
应付债券0--0000
其他非流动负债3,403,755-2.43%3,488,4073,181,6055,387,2245,127,858
10,003,1357.86%9,274,5629,441,40412,544,9756,311,936

总权益
    实收股本3,703,5230.01%3,703,3013,697,5462,842,0892,842,089
    储备项目66,287,1612.26%64,820,84263,365,46046,517,39142,512,588
股东权益69,990,6842.14%68,524,14367,063,00649,359,48045,354,678
非控股权益12,237,9373.69%11,801,95010,939,4459,706,7309,386,052